{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:21:26Z","timestamp":1762082486076,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100015090","name":"Imam Abdulrahman Bin Faisal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.amjms.2022.07.011","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T12:09:15Z","timestamp":1658750955000},"page":"766-771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pneumococcal empyema: Resistance patterns, fitness cost and serotype distribution"],"prefix":"10.1016","volume":"364","author":[{"given":"Amani","family":"Alnimr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.amjms.2022.07.011_bib0001","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/thx.2010.156406","article-title":"Emergence of parapneumonic empyema in the USA","volume":"66","author":"Grijalva","year":"2011","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.amjms.2022.07.011_bib0002","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.chest.2019.11.040","article-title":"Two Decades of Thoracic Empyema in Ontario, Canada","volume":"157","author":"Nayak","year":"2020","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.amjms.2022.07.011_bib0003","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.athoracsur.2018.02.027","article-title":"Current State of Empyema Management","volume":"105","author":"Semenkovich","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.amjms.2022.07.011_bib0004","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.athoracsur.2019.05.090","article-title":"Outcomes of Operative and Nonoperative Treatment of Thoracic Empyema: a Population-Based Study","volume":"108","author":"Nayak","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.amjms.2022.07.011_bib0005","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00542-2019","article-title":"The microbiology of pleural infection in adults: a systematic review","volume":"54","author":"Hassan","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.amjms.2022.07.011_bib0006","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/JCM.41.1.521-522.2003","article-title":"Culture-negative childhood empyema is usually due to penicillin-sensitive Streptococcus pneumoniae capsular serotype 1","volume":"41","author":"Eltringham","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.amjms.2022.07.011_bib0007","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001366","article-title":"Clinical utility of 16S rRNA PCR in pleural infection","volume":"70","author":"Lampejo","year":"2021","journal-title":"J Med Microbiol"},{"issue":"4","key":"10.1016\/j.amjms.2022.07.011_bib0008","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1086\/338460","article-title":"An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations","volume":"34","author":"Byington","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.amjms.2022.07.011_bib0009","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/thx.2003.016105","article-title":"Clinical features, aetiology and outcome of empyema in children in the north east of England","volume":"59","author":"Eastham","year":"2004","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.amjms.2022.07.011_bib0010","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/JCM.01200-09","article-title":"Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah","volume":"48","author":"Byington","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.amjms.2022.07.011_bib0011","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/CVI.00765-12","article-title":"Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey","volume":"20","author":"Ceyhan","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.amjms.2022.07.011_bib0012","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/1817-1737.180030","article-title":"The Saudi Thoracic Society pneumococcal vaccination guidelines-2016","volume":"11","author":"Alharbi","year":"2016","journal-title":"Ann Thorac Med"},{"issue":"18","key":"10.1016\/j.amjms.2022.07.011_bib0013","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2022.07.011_bib0014","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1469-0691.2008.02685.x","article-title":"Fitness cost of drug resistance in Mycobacterium tuberculosis","volume":"15","author":"Gagneux","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"1442","key":"10.1016\/j.amjms.2022.07.011_bib0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1098\/rspb.2000.1030","article-title":"Pervasive compensatory adaptation in Escherichia coli","volume":"267","author":"Moore","year":"2000","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.amjms.2022.07.011_bib0016","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-60327-279-7_9","article-title":"Methods to determine fitness in bacteria","volume":"642","author":"Pope","year":"2010","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.amjms.2022.07.011_bib0017","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1073\/pnas.1812388116","article-title":"Unraveling the seasonal epidemiology of pneumococcus","volume":"116","author":"Domenech de Cell\u00e8s","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.amjms.2022.07.011_bib0018","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/AAC.01161-06","article-title":"Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae","volume":"51","author":"Rozen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.amjms.2022.07.011_bib0019","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1086\/501367","article-title":"Incremental increase in fitness cost with increased beta -lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonization model","volume":"193","author":"Trzcinski","year":"2006","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.amjms.2022.07.011_bib0020","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1469-0691.2008.02058.x","article-title":"Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000-2004)","volume":"14","author":"Shibl","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.amjms.2022.07.011_bib0021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/INF.0000000000000041","article-title":"Parapneumonic pleural effusions caused by Streptococcus pneumoniae serotype 3 in children immunized with 13-valent conjugated pneumococcal vaccine","volume":"33","author":"Antachopoulos","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.amjms.2022.07.011_bib0022","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/cid\/cix115","article-title":"Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era","volume":"64","author":"Olarte","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.amjms.2022.07.011_bib0023","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","article-title":"Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine","volume":"26","author":"Pelton","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.amjms.2022.07.011_bib0024","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/INF.0b013e318187e215","article-title":"Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome","volume":"28","author":"R\u00fcckinger","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.amjms.2022.07.011_bib0025","first-page":"1210","article-title":"Penicillin resistance in serogroups\/serotypes of Streptococcus pneumoniae causing invasive infections in Central Saudi Arabia","volume":"24","author":"Twum-Danso","year":"2003","journal-title":"Saudi Med J"},{"issue":"1","key":"10.1016\/j.amjms.2022.07.011_bib0026","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijantimicag.2003.05.008","article-title":"Streptococcus pneumoniae in Saudi Arabia: antibiotic resistance and serotypes of recent clinical isolates","volume":"23","author":"Memish","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 2","key":"10.1016\/j.amjms.2022.07.011_bib0027","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjms.2022.07.011_bib0028","unstructured":"Active Bacterial Core Surveillance (ABCs): emerging Infections Program Network. Streptococcus pneumoniae, 2014. http:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/spneu14.html (Accessed on April 20, 2022)."},{"issue":"6","key":"10.1016\/j.amjms.2022.07.011_bib0029","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/AAC.48.6.2101-2107.2004","article-title":"High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study)","volume":"48","author":"Song","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.amjms.2022.07.011_bib0030","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/AAC.01797-09","article-title":"Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States","volume":"54","author":"Jacobs","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.amjms.2022.07.011_bib0031","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/CMR.00058-15","article-title":"Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective","volume":"29","author":"Kim","year":"2016","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.amjms.2022.07.011_bib0032","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/JCM.00517-11","article-title":"Clonal evolution leading to maintenance of antibiotic resistance rates among colonizing Pneumococci in the PCV7 era in Portugal","volume":"49","author":"Sim\u00f5es","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.amjms.2022.07.011_bib0033","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1046\/j.1532-5415.2003.51501.x","article-title":"Active Bacterial Core Surveillance Team. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community","volume":"51","author":"Kupronis","year":"2003","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"10.1016\/j.amjms.2022.07.011_bib0034","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1128\/AAC.46.8.2671-2675.2002","article-title":"Incidence, epidemiology, and characteristics of quinolone-nonsusceptible Streptococcus pneumoniae in Croatia","volume":"46","author":"Pankuch","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.amjms.2022.07.011_bib0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jac\/48.5.659","article-title":"Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000","volume":"48","author":"Ho","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.amjms.2022.07.011_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154816","article-title":"Belgian Streptococcus pneumoniae Study Group, Tulkens PM, Vanhoof R. Molecular Analysis of Rising Fluoroquinolone Resistance in Belgian Non-Invasive Streptococcus pneumoniae Isolates (1995-2014)","volume":"11","author":"Ceyssens","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.amjms.2022.07.011_bib0037","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijmm.2010.05.004","article-title":"CAPNETZ study group. Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage","volume":"301","author":"Pletz","year":"2011","journal-title":"Int J Med Microbiol"},{"issue":"12","key":"10.1016\/j.amjms.2022.07.011_bib0038","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.4014\/jmb.1105.05045","article-title":"pep27 and lytA in Vancomycin-Tolerant Pneumococci","volume":"21","author":"Olivaris","year":"2011","journal-title":"J Microbiol Biotechnol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922003354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922003354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:16:29Z","timestamp":1762082189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962922003354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0002962922003354"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2022.07.011","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal empyema: Resistance patterns, fitness cost and serotype distribution","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2022.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}